A nomogram based on quantitative MR signal intensity predicts early response to combined systemic treatment in patients with hepatocellular carcinoma
The nomogram based on rSI_ap has the potential to be a non-invasive tool for predicting disease control in advanced HCC patients who have received combined anti-angiogenesis and ICI therapies.
Authors
- Xiangwen Xia (ORCID: https://orcid.org/0000-0002-5798-1909)
- Haohao Lu (ORCID: https://orcid.org/0000-0002-7037-6279)
- Xiangjun Dong (ORCID: https://orcid.org/0000-0001-9491-9461)
- Ran Tao (ORCID: https://orcid.org/0000-0002-9962-1768)
- Hongjie Fan (ORCID: https://orcid.org/0000-0002-0211-2888)
- Zhaoming Tang (ORCID: https://orcid.org/0000-0002-6890-5557)
- Qian Ren
Institutions
- Union Hospital (HK)
- Wuhan Union Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-03-13
- DOI
- https://doi.org/10.3389/fonc.2025.1527108
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.32